News Daily News Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study Michael O'Riordan January 22, 2025
News Daily News CMS Announces Negotiated Medicare Prices for First 10 Drugs Yael L. Maxwell August 16, 2024
News Conference News ACC 2024 Need a Statin for Primary Prevention? There’s an App for That Michael O'Riordan April 10, 2024
News Daily News First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists L.A. McKeown August 31, 2023
News Conference News AHA 2021 An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops Shelley Wood November 15, 2021
News Daily News Could an App Replace Statin Prescribing by Doctors? Michael O'Riordan September 08, 2021
News Daily News VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks Michael O'Riordan September 24, 2020
News Daily News Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval Michael O'Riordan May 01, 2018
News Daily News FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen Michael O'Riordan April 25, 2018
News Daily News FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled Michael O'Riordan April 24, 2018
News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Daily News Lp(a) Not Associated With Adverse Cardiovascular Events in ACS Patients Michael O'Riordan October 26, 2017
News Conference News ESC 2017 Women at High Cardiovascular Risk Unlikely to Get to Low LDL Targets Michael O'Riordan August 30, 2017
News Conference News ESC 2017 Anacetrapib Finds (Modest) Success Where All Other CETP Inhibitors Failed Michael O'Riordan August 29, 2017
News Conference News ESC 2017 ESC Updates Guidelines for Treating STEMI Patients Michael O'Riordan August 27, 2017
News Daily News Evolocumab Not Cost-Effective at Current List Price Michael O'Riordan August 23, 2017
News Daily News Top-Line REVEAL Results Support Efficacy of CETP Inhibition, but Questions Abound Todd Neale June 27, 2017
News Daily News $2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor Michael O'Riordan May 12, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017